Status: current, Defined. Date: 30-Jun 2009. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2454461000168113 | Cystagon 150 mg capsule | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| 2454471000168119 | Cystagon (mercaptamine (cysteamine) 150 mg) capsule (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Cystagon 150 mg capsule | has manufactured dose form | capsule | true | Inferred relationship | Some | ||
| Cystagon 150 mg capsule | has intended active ingredient | mercaptamine (cysteamine) | true | Inferred relationship | Some | 737161578 | |
| Cystagon 150 mg capsule | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Cystagon 150 mg capsule | Is a | Cystagon | true | Inferred relationship | Some | ||
| Cystagon 150 mg capsule | Is a | mercaptamine (cysteamine) 150 mg capsule | true | Inferred relationship | Some | ||
| Cystagon 150 mg capsule | has manufactured dose form | hard capsule | false | Inferred relationship | Some | ||
| Cystagon 150 mg capsule | has Australian BoSS | mercaptamine (cysteamine) | true | Inferred relationship | Some | 737161578 | |
| Cystagon 150 mg capsule | has unit of use | capsule | true | Inferred relationship | Some | 737161579 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Cystagon 150 mg capsule, 500 | has TPUU | True | Cystagon 150 mg capsule | Inferred relationship | Some | 1 |
| Cystagon 150 mg capsule, 500, bottle | has TPUU | True | Cystagon 150 mg capsule | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR